Nephros, Inc. (NEPH)
- Previous Close
1.4600 - Open
1.4700 - Bid --
- Ask --
- Day's Range
1.4479 - 1.4700 - 52 Week Range
1.4300 - 4.0400 - Volume
2,082 - Avg. Volume
13,446 - Market Cap (intraday)
15.267M - Beta (5Y Monthly) 1.18
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1200 - Earnings Date Nov 6, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
www.nephros.comRecent News: NEPH
View MorePerformance Overview: NEPH
Trailing total returns as of 10/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NEPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NEPH
View MoreValuation Measures
Market Cap
15.39M
Enterprise Value
13.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.11
Price/Book (mrq)
1.94
Enterprise Value/Revenue
1.01
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.40%
Return on Assets (ttm)
-7.96%
Return on Equity (ttm)
-15.61%
Revenue (ttm)
13.77M
Net Income Avi to Common (ttm)
-1.29M
Diluted EPS (ttm)
-0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
3.08M
Total Debt/Equity (mrq)
19.93%
Levered Free Cash Flow (ttm)
-235.88k